The weekly litigation news digest is live. Subscribe now

IP Verse

Stabilized Non-Protein Clostridial Toxin Compositions - EP3432916

The patent EP3432916 was granted to Allergan on Aug 14, 2019. The application was filed on Sep 13, 2017 under application number EP17777119A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3432916

ALLERGAN
Application Number
EP17777119A
Filing Date
Sep 13, 2017
Status
Granted And Under Opposition
Jul 12, 2019
Publication Date
Aug 14, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
IPSEN PHARMAMay 12, 2020PLASSERAUD -

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2010203559
DESCRIPTIONUS2010233802
DESCRIPTIONUS7354740
INTERNATIONAL-SEARCH-REPORTEP2692350
INTERNATIONAL-SEARCH-REPORTUS2016250302
INTERNATIONAL-SEARCH-REPORTWO2007041664
OPPOSITIONAU2009339292B
OPPOSITIONEP2679217
OPPOSITIONEP2692350
OPPOSITIONUS2007134199
OPPOSITIONWO0158472

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents